Skip to main content
. 2020 Feb 20;15:92–102. doi: 10.1515/med-2020-0014

Table 2.

Overall survival stratified by clinical characteristics and univariate Cox proportional hazard analyses for patients

Univariate analysis
Variables
Mean survival (months) 95% CI HR(95%CI) P-value
Total 32.6 (31.2-33.9)
Age
<=78 33.9 (32.4-35.5) Ref
>78 23.2 (20.5-25.8) 1.29(1.13-1.43) <0.001
Gender
Female 21.8 (20.33-23.31) Ref
Male 20.9 (19.35-22.52) 1.06(0.97-1.15) 0.202
Race
White 21.6 (20.37-22.89) Ref
Black 17.3 (14.33-20.19) 1.13(0.97-1.31) 0.110
Other 23.3 (20.35-26.29) 0.92(0.8-1.05) 0.200
Marital status
Married 22.4 (20.96-23.86) Ref
Single 20.0 (18.3-21.75) 1.06(0.97-1.16) 0.232
Laterality
Right 21.9 (20.43-23.3) Ref
Left 22.3 (20.35-24.16) 1.07(0.98-1.17) 0.153
Bilateral 15.9 (9.83-22.04) 2.49(1.87-3.32) <0.0001
Lobe
Upper 12.3 (8.01-16.57) Ref
Middle 22.0 (20.41-23.69) 0.75(0.6-0.93) 0.011
Lower 29.7 (21.3-38.04) 0.92(0.83-1.02) 0.956
Main bronchus 24.9 (22.79-27.1) 2.19(1.62-2.95) <0.001
Overlapping lesion of lung 20.0 (12-28) 1.33(0.93-1.89) 0.113
Grade
Well; I 30.6 (26.82-34.48) Ref
Moderately; II 28.0 (25.5-30.5) 1.14(0.98-1.32) 0.098
Poorly; III 21.1 (17.94-24.32) 1.94(1.62-2.32) <0.001
Undifferentiated; IV 21.0 (10.32-31.68) 1.47(0.9-2.41) 0.122
Node status
N0 29.4 (26.87-31.9) Ref
N1-3 19.5 (18.16-20.89) 2.93(2.64-3.25) <0.001
Metastasis status
M0 28.9 (27.05-30.77) Ref
M1 13.8 (12.77-14.74) 3.62(3.29-3.97) <0.001
Tumor size
<=38mm 41.7 (39.4-44.1) Ref
>38mm 29.6 (27.2-31.9) 1.88(1.69-2.10) <0.001
Surgery
Yes 35.8 (33.38-38.23) Ref
No 14.3 (13.44-15.21) 4.77(4.33-5.26) <0.001
Surgery type
Lobectomy/Bilobectomy 52.8 (49.9-55.6) Ref
Partial resection 43.7 (32.1-55.4) 1.83(1.33-2.5) <0.001
Pneumonectomy 39.4 (33.9-44.8) 1.8(1.49-2.17) <0.001
Radiation
Yes 22.8 (21.3-24.22) Ref
No 19.1 (17.57-20.71) 0.52(0.47-0.57) <0.001
Chemotherapy
No 22.5 (20.77-24.14) Ref
Yes 20.3 (18.95-21.66) 1.8(1.64-1.96) <0.001

Abbreviation: 95% CI, 95% Confidence interval